The BIO-TECHNOPARK® Schlieren-Zurich, in close collaboration with its network partners, offers professional support for life science companies in the setting up and expansion of business activities in the Greater Zurich Area. There is a healthy spread of firms at varying stages of business development in Schlieren, which range from recent start-ups to global players. In 2003 these firms joined forces in the non-profit organization formerly named Biotech Center Zurich with the owner of the Wagi site, the town of Schlieren and the Canton of Zurich’s Department for Economic Development in order to simplify both their internal and external communication and to identify and maximize synergies.
In 2010 the center changed its name to BIO-TECHNOPARK® Schlieren-Zurich to closely co-operate with
the TECHNOPARK® Zurich Foundation. BIO-TECHNOPARK® Schlieren-Zurich hit the headlines with the sale of the young start-up Glycart to Roche for 235 million CHF in 2005, and also on the takeover of ESBATech by Alcon, a Novartis company, for about 600 million USD in 2009.
Rental area: 30,000 m2
Tenants: 36
Member of TECHNOPARK®-Alliance, Life Science Zurich Business Network, Swiss Biotech Association and the EU consortium HealthTIES